Influence
February 16, 2022

‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia

NiCole Keith on virtual panel

Regenstrief Institute Research Scientist NiCole Keith, PhD, addressed the many challenges faced by the growing number of older Hoosiers living with dementia. She was a guest presenter at a webinar event organized by Indianapolis’ public broadcasting station WFYI and SAVI, an online community information system enabling people and organizations to make data-informed decisions.

Dr. Keith, an expert in physical fitness, community activation and health equity research, was joined by Steven Counsell, M.D., professor of medicine at IU School of Medicine and founding director, IU Geriatrics Program from 1997-2016 and former chief of geriatrics, Eskanazi Health.

Dr. Keith emphasized that, “Memory loss is not normal aging. Our goal is to influence geriatric care by all healthcare professionals through early education. We shouldn’t miss the dementia diagnosis.” Early diagnosis of dementia has many benefits including timely provision of counseling and caregiver support and appropriate medical care.

Dr. Keith helped inform attendees about evidence-based dementia care services developed in Indiana that improve health outcomes of adults with dementia and reduce caregiver stress.

In addition to participating in the webinar, Dr. Keith helped write the State of Aging Report for Central Indiana. Supported by the Central Indiana Senior Fund and convened by the Polis Center, the goal of the report is to inspire community leaders and organizations to envision potential programs, funding, and policies that will help Central Indiana seniors have equal opportunity for a healthier and more fulfilling life.

Watch the entire webinar.

In addition to her role as a research scientist at Regenstrief, Dr. Keith is the associate dean of faculty affairs and a professor at Indiana University School of Health & Human Sciences.

Related News

Johanne Eliacin and Sophia Wang

Factors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research

Regenstrief researcher leads study of barriers to participation and drivers of engagement The use of Alzheimer’s disease (AD) biomarkers

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Study also finds less severe disease during BA.4/BA.5 predominance compared to earlier Omicron variants A multi-state study from the

Dr. Kurt Kroenke at the 2023 Indianapolis Business Journal's Health Care Heroes Awards Breakfast

IBJ Honors Regenstrief research scientist with Heath Care Hero Award 

The Indianapolis Business Journal (IBJ) honored Regenstrief Research Scientist Kurt Kroenke, M.D., MACP, as a Health Care Hero at

LOINC Logo

LOINC 2.74 Release Webinar scheduled for spring 2023

LOINC® from Regenstrief Institute will host an educational webinar for the February 2023 2.74 release of new concepts, scheduled